• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER ORTHOBIOLOGICS-MALVERN CORTOSS 10CC OUS; POLYMETHYLMETHACRYLATE (PMMA) BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER ORTHOBIOLOGICS-MALVERN CORTOSS 10CC OUS; POLYMETHYLMETHACRYLATE (PMMA) BONE CEMENT Back to Search Results
Catalog Number 2101-0000
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Spinal Cord Injury (2432)
Event Date 09/09/2019
Event Type  Injury  
Manufacturer Narrative
The product was reported to be a cortoss 10 cc ous catalog #2101-0000, lot #a1903028.Inspection and device evaluation could not be performed because the product was not returned.A review of product history identified no relevant manufacturing issues and a review of complaint history identified no similar complaints.The cortoss ifu includes the following: pedicle screw augmentation requires application of cortoss in a specific sequence.If one level is being treated, the first augmented screw in a given vertebra must be allowed to cure before the second screw of the same vertebra is augmented.This is because of the pressure gradients that may occur in the enclosed vertebral space.Alternating lateral and a/p views should be used to ensure that the filling volume is visualized.If more than one level is being treated, each level must be completed sequentially on one side before treating the other side, i.E.Treat all screws on the left side, followed by all screws on the right side or vice versa.In any single vertebra treated with cortoss, one side must be allowed to polymerize (harden) before the contralateral pedicle is augmented.Use of cortoss bone augmentation material is contraindicated in the presence of one or more of the following clinical situations: for screw augmentation: breach of the pedicle wall when augmenting pedicle screws.Injection of cortoss in this situation will carry a high risk of leakage into the spinal canal or neural foramen.Cement leakage may cause tissue damage, nerve or circulatory problems, and other serious adverse events.The surgeon reportedly breached the pedicle on two or three levels; therefore, the most plausible root cause for the reported event is that the pedicle was breached.
 
Event Description
It was reported that a physician encountered difficulties using cortoss.Per the company representative, the cortoss had 45 minutes to an hour to equilibrate before being used.The patient had poor bone quality and the vertebral bodies were filled with approximately 2 cc of cortoss.The pedicle was breached on two or three levels and cortoss leaked onto the spinal cord.Approximately 1.5 hours after the injection, the patient¿s motor function decreased; noted through neuro monitoring.There was a two- hour extension of surgery as the physician removed the screws, lamina, and cortoss which had leaked along the cord.The patient¿s motor functions completely returned after a couple of hours.The patient's spine was left without instrumentation, with no plans to revise.This record captures the second of two units of cortoss.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CORTOSS 10CC OUS
Type of Device
POLYMETHYLMETHACRYLATE (PMMA) BONE CEMENT
Manufacturer (Section D)
STRYKER ORTHOBIOLOGICS-MALVERN
45 great valley parkway
malvern PA 19355
Manufacturer (Section G)
STRYKER ORTHOBIOLOGICS-MALVERN
45 great valley parkway
malvern PA 19355
Manufacturer Contact
margarita karan
2 pearl court
allendale, NJ 07401
2017608000
MDR Report Key9469921
MDR Text Key188507736
Report Number0002530131-2019-00005
Device Sequence Number1
Product Code NDN
Combination Product (y/n)N
Reporter Country CodeGB
PMA/PMN Number
K080108
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2022
Device Catalogue Number2101-0000
Device Lot NumberA1903028
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/09/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/21/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-